Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM
Harvard Bioscience Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.12 | 1.28K | -6.11 | -10.33 | -9.85 | -31.42 | -37.04 | -59.32 | 71.10 | -17.5 | -7.83 | 15.27 | -9.13 | 74.90 | -418.33 | -203.94 | -81.18 |
PEG Ratio | 0.00 | -12.71 | -0.1 | 0.27 | -0.06 | -0.67 | -1.45 | 0.23 | -0.52 | 0.34 | 0.03 | -0.11 | 0.01 | -0.13 | 7.11 | 5.19 | -12.83 |
PS Ratio | 1.15 | 3.74 | 5.34 | 5.23 | 7.54 | 8.12 | 7.24 | 8.09 | 5.90 | 4.10 | 3.96 | 5.09 | 8.73 | 8.71 | 9.59 | 11.46 | 8.05 |
PB Ratio | 1.68 | 1.45 | 1.80 | 1.80 | 2.69 | 3.13 | 2.47 | 3.08 | 2.38 | 1.61 | 1.48 | 1.92 | 3.29 | 3.45 | 3.70 | 4.25 | 2.82 |
P/FCF Ratio | 10.09 | 64.51 | -78.27 | -66.72 | 270.71 | 70.48 | 46.35 | 79.44 | 111.40 | 47.72 | 514.93 | -235.28 | -102.29 | -1.19K | -249.53 | 595.14 | 295.16 |
P/OCF Ratio | 8.36 | 53.26 | -139.34 | -142.9 | 131.78 | 53.10 | 42.09 | 65.46 | 97.63 | 43.53 | 164.24 | -782.6 | -126.55 | 2.46K | -431 | 435.50 | 209.49 |
OCF/S Ratio | 0.14 | 0.07 | -0.04 | -0.04 | 0.06 | 0.15 | 0.17 | 0.12 | 0.06 | 0.09 | 0.02 | -0.01 | -0.07 | 0.00 | -0.02 | 0.03 | 0.04 |
Debt / Equity Ratio | 3.01 | 0.70 | 0.70 | 0.62 | 0.60 | 0.59 | 0.52 | 0.55 | 0.59 | 0.65 | 0.68 | 0.73 | 0.75 | 0.58 | 0.59 | 0.66 | 0.68 |
Quick Ratio | 0.40 | 0.40 | 0.91 | 0.94 | 0.94 | 0.92 | 1.02 | 1.16 | 1.10 | 1.06 | 1.20 | 1.16 | 1.13 | 1.34 | 1.26 | 1.24 | 1.28 |
Current Ratio | 0.81 | 0.82 | 2.06 | 2.05 | 1.88 | 1.85 | 2.09 | 2.29 | 2.26 | 2.20 | 2.43 | 2.42 | 2.18 | 2.43 | 2.37 | 2.30 | 2.38 |
Asset Turnover | 0.27 | 0.19 | 0.17 | 0.18 | 0.18 | 0.20 | 0.18 | 0.20 | 0.21 | 0.20 | 0.18 | 0.19 | 0.18 | 0.20 | 0.19 | 0.19 | 0.18 |
Interest Coverage | 49.97 | 0.01 | -2.19 | -2.43 | -1.75 | 0.36 | -1.06 | 0.85 | 1.80 | -0.51 | -5.75 | -1.83 | -17.48 | 4.48 | 1.47 | 0.15 | -0.58 |
Return on Equity | -3.39 | n/a | -0.07 | -0.04 | -0.07 | -0.02 | -0.02 | -0.01 | 0.01 | -0.02 | -0.05 | 0.03 | -0.09 | 0.01 | n/a | -0.01 | -0.01 |
Return on Assets | -0.63 | n/a | -0.04 | -0.02 | -0.04 | -0.01 | -0.01 | -0.01 | n/a | -0.01 | -0.02 | 0.02 | -0.04 | 0.01 | n/a | n/a | n/a |
Return on Invested Capital | -0.65 | n/a | -0.02 | -0.01 | -0.01 | n/a | -0.02 | n/a | 0.01 | -0.01 | -0.02 | n/a | -0.05 | 0.01 | -0.02 | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.56 | 0.57 | 0.58 | 0.51 | 0.55 | 0.53 | 0.58 | 0.58 | 0.61 | 0.56 | 0.45 | 0.57 | 0.56 | 0.59 | 0.55 | 0.56 | 0.57 |
Net Profit Margin | -2.31 | 0.00 | -0.22 | -0.13 | -0.19 | -0.06 | -0.05 | -0.03 | 0.02 | -0.06 | -0.13 | 0.08 | -0.24 | 0.03 | -0.01 | -0.01 | -0.02 |
Pretax Profit Margin | -2.33 | 0.02 | -0.2 | -0.14 | -0.18 | -0.04 | -0.02 | -0.07 | 0.04 | -0.03 | -0.17 | 0.12 | -0.24 | 0.03 | 0.00 | -0.02 | -0.03 |
Operating Profit Margin | -1.84 | 0.00 | -0.09 | -0.08 | -0.05 | 0.01 | -0.04 | 0.03 | 0.06 | -0.02 | -0.16 | -0.03 | -0.23 | 0.05 | 0.02 | 0.00 | -0.01 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.84 | 0.13 | -0.09 | -0.03 | -0.09 | 0.05 | 0.03 | 0.02 | 0.12 | 0.12 | -0.07 | 0.03 | -0.17 | 0.12 | 0.09 | 0.06 | 0.06 |